Repligen
RGEN
#2090
Rank
ยฃ7.34 B
Marketcap
ยฃ130.21
Share price
-3.16%
Change (1 day)
44.00%
Change (1 year)
Categories

Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Volume in USD (price x number of shares), data since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026ยฃ41.01 M87.53%
2025ยฃ21.87 M-36.33%
2024ยฃ34.35 M-68.17%
2023ยฃ0.10 B60.05%
2022ยฃ67.43 M90.89%
2021ยฃ35.32 M-76.42%
2020ยฃ0.14 B197.63%
2019ยฃ50.34 M-29.09%
2018ยฃ70.99 M835.37%
2017ยฃ7.59 M22.08%
2016ยฃ6.21 M-19.68%
2015ยฃ7.74 M-7.23%
2014ยฃ8.34 M721.71%
2013ยฃ1.01 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
ยฃ0.20 Bยฃ0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ40.46 Mยฃ83.84 M๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ0.18 Bยฃ0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ26.69 Mยฃ82.37 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ1.32 Mยฃ5.69 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ16.73 Mยฃ54.44 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ92.19 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ0.10 Bยฃ0.13 B๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.37 Mยฃ15.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ37.76 Mยฃ0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA